Pulmonary Disease, Chronic Obstructive
Conditions
Keywords
Yoga, COPD, rehabilitation
Brief summary
COPD patients will be recruited and assigned into one of each group: 1) Control group or 2) Yoga group. In Yoga groups, subjected will be asked to participate in Modified Dantien Yoga training for 12 weeks (3 times/week, 60 min/time). The subjects will be evaluated their pulmonary function, functional fitness performance, dyspnea score, and quality of life at baseline and after 12 wk training.
Interventions
OTHERModified Dantien Salee Yoga Training Program
The intervention aims to improve pulmonary function and functional fitness.
Sponsors
Mahidol University
Study design
Allocation
NON_RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
NONE
Intervention model description
Detail of intervention is Yoga training program. 3 times /week ,12 weeks .
Eligibility
Sex/Gender
ALL
Age
50 Years to 80 Years
Healthy volunteers
No
Inclusion criteria
1. Stable COPD patients \> or equal 6 weeks. 2. Age \> or equal 50-80 years. 3. FEV1 \> or equal 30% predicted after take bronchodilators drug. 4. Resting SpO2 \> or equal 90% room air. 5. Did not pulmonary rehabilitation program before start the yoga
Exclusion criteria
1. Subjects with musculoskeletal disorders, mental and neurological disorders, and acute coronary heart disease. 2. Blood Pressure (systolic) \> 180 mmHg.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Change from baseline Exercise Capacity assessed with 6-minute walk test at 12 weeks | 12 weeks | Change from baseline Exercise Capacity assessed with 6-minute walk test (meter) |
| Change from baseline upper body flexibility assessed with Back Scratch test at 12 weeks | 12 weeks. | Change from baseline upper body flexibility assessed with Back Scratch test (cm) |
| Change from baseline agility/dynamic balance assessed with 8-foot Up and Go test at 12 weeks | 12 weeks | Change from baseline agility/dynamic balance assessed with 8-foot Up and Go test (sec) |
| Change from baseline FVC (Forced Vital Capacity) (L) at 12 weeks | 12 weeks | Change of FVC (Forced Vital Capacity) will be measured on a computerized Spirometer at the baseline and 12 weeks. |
| Change from baseline FEV1 (Forced Expiratory Volume in 1 minute)(L) at 12 weeks | 12 weeks | Change of Forced Expiratory Volume in 1 second will be measured on a computerized Spirometer at the baseline and 12 weeks. |
| Change from baseline TLC (Total Lung Capacity) (L) at 12 weeks | 12 weeks | Change of TLC (Total Lung Capacity) (L) will be measured on a computerized Spirometer at the baseline and 12 weeks. |
| Change from baseline FRC (Functional Residual Capacity) (L) at 12 weeks | 12 weeks | Change of FRC (Functional Residual Capacity) (L) will be measured on a computerized Spirometer at the baseline and 12 weeks. |
| Change from baseline IC (Inspiratoy Capacity) (L) at 12 weeks | 12 weeks | Change of IC (Inspiratoy Capacity) (L) will be measured on a computerized Spirometer at the baseline and 12 weeks. |
| Change from baseline RV (Residual Volume) (L) at 12 weeks | 12 weeks | Change of RV (Residual Volume) (L) will be measured on a computerized Spirometer at the baseline and 12 weeks. |
| Change from baseline MVV (Maximum Voluntary Ventilation) (L/min) at 12 weeks | 12 weeks | Change of MVV (Maximum Voluntary Ventilation) (L/min) will be measured on a computerized Spirometer at the baseline and 12 weeks. |
| Change from baseline PEFR (Peak Expiratory Flow Rate) (L/sec) at 12 weeks | 12 weeks | Change of MVV (Maximum Voluntary Ventilation) (L/sec) will be measured on a computerized Spirometer at the baseline and 12 weeks. |
| Change from baseline DLCO (Diffusion capacity to carbon monoxide) (ml/mmHg/min) at 12 weeks | 12 weeks | Change of DLCO (Diffusion capacity to carbon monoxide) (ml/mmHg/min) will be measured on a computerized Spirometer at the baseline and 12 weeks. |
| Change from baseline PI max (Maximal Inspiratoy Pressure) (cm H2O) at 12 weeks | 12 weeks | Change of PI max (Maximal Inspiratoy Pressure) (cm H2O) will be measured on a computerized Spirometer at the baseline and 12 weeks. |
| Change from baseline PE max (Maximal Expiratoy Pressure) (cm H2O) at 12 weeks | 12 weeks | Change of PE max (Maximal Expiratoy Pressure) (cm H2O) will be measured on a computerized Spirometer at the baseline and 12 weeks. |
| Change from baseline FEV1/FVC % predicted at 12 weeks | 12 weeks | Change of FEV1/FVC % Predicted (Percent Predicted of ratio of FEV1 and FVC) (% predicted) will be measured on a computerized Spirometer at the baseline and 12 weeks. |
| Change from baseline lower body strength assessed with Chair Standing test at 12 weeks | 12 weeks | Change from baseline lower body strength assessed with Chair standing test. ( time/30 sec) |
| Change from baseline upper body strength assessed with Arm curl test at 12 weeks | 12 weeks | Change from baseline upper body strength assessed with Arm curl test (time/30 sec) |
| Change from baseline lower body flexibility assessed with Chair Sit and Reach test at 12 weeks | 12 weeks | Change from baseline lower body flexibility assessed with Chair Sit and Reach test (cm) |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Change from baseline Quality of life score assessed with St. George's respiratory Questionnaires (SGRQ) at 12 weeks. | 12 weeks | Change from baseline Quality of Life score assessed with St. George's respiratory Questionnaires (SGRQ) in Thai version at 12 weeks. |
| Change from baseline Dyspnea score assessed with visual analog scale at 12 weeks | 12 weeks | Dyspnea or shortness of breath will be measured by visual analog scale (VAS) 1-10 point scale at the baseline and 12 weeks. |
Countries
Thailand
Contacts
Primary ContactDuangjun Phantayuth, M.Sc.
Outcome results
None listed